4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-013042
Options or other derivatives
- Chief Executive Officer acquired 1,669,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Collard Craig A Chief Executive Officer | 2025-01-31 | Grant or award · Employee Stock Option (Right to Buy) | +1,113,240 | 1,113,240 | D: show line 1 in the form | |||||
| Collard Craig A Chief Executive Officer | 2025-01-31 | Grant or award · Restricted Stock Units | +556,620 | 556,620 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…